Literature DB >> 2434204

Small cell carcinoma of the prostate. II. Immunohistochemical and electron microscopic studies of 18 cases.

J Y Ro, B Têtu, A G Ayala, N G Ordóñez.   

Abstract

To evaluate the histogenesis of small cell carcinoma of the prostate, 18 cases of this tumor (9 pure small cell and 9 combined adeno- and small cell carcinoma) were studied using immunohistochemical methods. Seven of the small cell components also were assessed by electron microscopic examination. Using neuron-specific enolase (NSE), prostatic acid phosphatase (PAP), and prostate-specific antigen (PSA) on tissue sections, three distinctive immunostaining patterns of small cell carcinoma components were identified: staining positive for NSE and negative for PSA and PAP (10 cases), staining positive for PSA and PAP and negative for NSE (3 cases), and negative reaction for all three antigens (5 cases). Electron microscopic study demonstrated neurosecretory granules in two cases. Based on the immunostaining and electron microscopic findings, small cell carcinomas of the prostate appear to be a heterogeneous group of tumors. Some of them are neuroendocrine carcinomas whereas others are poorly differentiated adenocarcinomas or, possibly, reserve cell carcinomas. Differences in immunostaining patterns or presence and absence of adenocarcinoma component do not reflect any differences in the uniformly poor prognosis of small cell carcinomas, in which median survivals is 7.7 months. The authors believe that, because of such heterogeneity, small cell carcinomas of the prostate arise from multipotential prostatic epithelium and that an origin from specific neuroendocrine cells need not be implicated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434204     DOI: 10.1002/1097-0142(19870301)59:5<977::aid-cncr2820590521>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Case report: subcutaneous metastasis from small cell carcinoma of the prostate.

Authors:  Mustafa Kaplan; Irfan H Atakan; Selcuk Bilgi; Osman Inci
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

2.  Prostatic neuroendocrine tumor in multiple endocrine neoplasia Type 2B.

Authors:  B Goulet-Salmon; E Berthe; S Franc; S Chanel; F Galateau-Salle; M Kottler; J Mahoudeau; Y Reznik
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

3.  Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer.

Authors:  Oleksandr N Kryvenko; Sean R Williamson; Kiril Trpkov; Nilesh S Gupta; Daniel Athanazio; Martin K Selig; Paul Taylor Smith; Cristina Magi-Galluzzi; Merce Jorda
Journal:  Virchows Arch       Date:  2016-10-14       Impact factor: 4.064

4.  Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.

Authors:  O I Turhan; N E Aydin; O Sariyüce; S Ozkan
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas.

Authors:  Brittany Kleb; Marcos R H Estécio; Jiexin Zhang; Vassiliki Tzelepi; Woonbok Chung; Jaroslav Jelinek; Nora M Navone; Salahaldin Tahir; Victor E Marquez; Jean-Pierre Issa; Sankar Maity; Ana Aparicio
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

Review 6.  Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature.

Authors:  C E Blomjous; F B Thunnissen; W Vos; H J de Voogt; C J Meijer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 8.  The evolving role of cytotoxic chemotherapy in the management of patients with metastatic prostate cancer.

Authors:  Elan Diamond; María del Carmen Garcias; Beerinder Karir; Scott T Tagawa
Journal:  Curr Treat Options Oncol       Date:  2015-02

9.  Do neuroendocrine cells in human prostate cancer express androgen receptor?

Authors:  J L Krijnen; P J Janssen; J A Ruizeveld de Winter; H van Krimpen; F H Schröder; T H van der Kwast
Journal:  Histochemistry       Date:  1993-11

Review 10.  Small cell carcinoma of the prostate.

Authors:  Rosa Nadal; Michael Schweizer; Oleksandr N Kryvenko; Jonathan I Epstein; Mario A Eisenberger
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.